banner
Progesterone receptor inhibitor ACT-129968, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ559

Progesterone receptor inhibitor ACT-129968, Purity ≥98%

Synonym: 866460-33-5; Progesterone receptor inhibitor; ACT 129968; ACT129968; KYTH-105; KYTH105; KYTH 105; Setipiprant

  • MDL: MFCD23136043
  • CAS Number: 866460-33-5
  • Compound CID: 49843471
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
ACT-129968, soluble in DMSO, is a compound that blocks the action of progesterone at its receptor sites. It targets EP2, hCRTH2, and hDP1.
Molecular Weight
402.43
Molecular Formula
C24H19FN2O3
Targets
EP2: 2600 nM; hCRTH2: 6 nM; hDP1: 1290 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 69 mg/mL (171.46 mM);
Identity
Confirmed by NMR/HPLC/MS.
Applications
ACT-129968 is used to study progesterone receptor function, with potential applications in reproductive health and contraception.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0